Library

Last modification: 2024/02/23 https://kinderkrebsinfo.de/doi/e8952

Autor(en) Titel Quelle Links
Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1992, 23: 313    
van Valen F, Winkelmann W, Burdach S, Göbel U, Jürgens H Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin Oncol 1993, 119: 615    
van Valen F, Hanenberg H, Jürgens H Expression of functional very late antigen-alpha 1-alpha 2-alpha 3 and -alpha 6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-gamma and tumour necrosis factor-alpha. Eur J Cancer 1994, 30A: 2119    
van Valen F, Kentrup-Lardong V, Truckenbrod B, Rübe C, Winkelmann W, Jürgens H Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma / peripheral primitive neuroectodermal tumour cells. J Cancer Res Clin Oncol 1997, 123: 245    
van Dongen J, Seriu T, Panzer-Grumayer E, Biondi A, Pongers-Willemse M, Corral L, Stolz F, Schrappe M, Masera G, Kamps W, Gadner H, van Wering E, Ludwig W, Basso G, de Bruijn M, Cazzaniga G, Hettinger K, Berg van, Hop W, Riehm H, Bartram C Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998, 352: 1731    
van den Heuvel-Eibrink MM, Graf N, Pein F, Sandstedt B, van Tinteren H, van der Vaart KE, de Kraker J Intracranial relapse in Wilms tumor patients. Pediatric blood & cancer 2004, 43: 737    
Vassal G, Fitzgerald E, Schrappe M, Arnold F, Kowalczyk J, Walker D, Hjorth L, Riccardi R, Kienesberger A, Jones KP, Valsecchi MG, Janic D, Hasle H, Kearns P, Petrarulo G, Florindi F, Essiaf S, Ladenstein R Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda. Pediatr Blood Cancer 2014 Apr 7    
Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet 2010, 42: 406    
Van der Velden VH, Corral L, Valsecchi MG, Jansen MW, De Lorenzo P, Cazzaniga G, Panzer-Grümayer ER, Schrappe M, Schrauder A, Meyer C, Marschalek R, Nigro LL, Metzler M, Basso G, Mann G, Den Boer ML, Biondi A, Pieters R, Van Dongen JJ, Interfant-99 Study Group Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia 2009, 23: 1073    
Velleuer E, Dietrich R Fanconi anemia: young patients at high risk for squamous cell carcinoma. Molecular and cellular pediatrics 2014, 1: 9    
Vetter B, Schwarz C, Kohne E, Kulozik AE Beta-thalassaemia in the immigrant and non-immigrant German populations. British journal of haematology 1997, 97: 266    
Vickers JL, Carlisle C Choices and control: parental experiences in pediatric terminal home care. Journal of pediatric oncology nursing 2000, 17: 12    
Vichinsky EP Clinical Manifestations of α-Thalassemia. Cold Spring Harbor perspectives in medicine 2013, 3    
Vieira Pinheiro J, Ahlke E, Nowak-Gottl U, Hempel G, Muller H, Lumkemann K, Schrappe M, Rath B, Fleischhack G, Mann G, Boos J Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols. Br J Haematol 1999, 104: 313    
Vieira Pinheiro P, Ahlke E, Nowak-Göttl U, Hempel G, Müller H, Lümkemann K, Schrappe M, Rath B, Fleischhack G, Mann G, Boos J Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols. Br J Haematol 1999, 104: 313    
Vieira Pinheiro J, Müller H, Schwabe D, Gunkel M, Casimiro Da Palma J, Henze G, Von Schutz V, Winkelhorst M, Wurthwein G, Boos J Drug monitoring of low-dose PEG-asparaginase (Oncaspar TM) in children with relapsed acute lymphoblastic leukaemia. Br J Haematol 2001, 113: 115    
Viehmann S, Reinhardt D, Griesinger F, Creutzig U, Harbott J Monitoring of minimal residual disease (MRD) in children with AML - comparison of two quantitative methods. Monatsschrift Kinderheilkunde 2002, 150: 553    
Viehmann S, Teigler-Schlegel A, Bruch J, Langebrake C, Reinhardt D, Harbott J Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement. Leukemia 2003, 17: 1130    
Virgone C, Roganovic J, Vorwerk P, Redlich A, Schneider DT, Janic D, Bien E, López-Almaraz R, Godzinski J, Osterlundh G, Stachowicz-Stencel T, Brugières L, Brecht IB, Thomas-Teinturier C, Fresneau B, Surun A, Ferrari A, Bisogno G, Orbach D Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatric blood & cancer 2021, 68 Suppl 4:e29025    
Vishnu P, Moreno Vanegas Y, Wadei HM, Rivera CE Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers. BMJ case reports 2018, 2018,bcr2018224622    
Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM, Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British journal of haematology 2008, 142: 859    
Vlachos A, Muir E How I treat Diamond-Blackfan anemia. Blood 2010, 116: 3715    
Vlachos A, Muir E How I treat Diamond-Blackfan anemia. Blood 2010, 116: 3715    
De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 May 15; 14: 3098    
Vogel F Genetics of retinoblastoma. Human genetics 1979, 52: 1    
Vogel F Genetics of retinoblastoma. Human genetics 1979, 52: 1    
Voges J, Sturm V, Berthold F, Pastyr O, Schlegel W, Lorenz WJ Interstitial irradiation of cerebral gliomas in childhood by permanently implanted 125-iodine--preliminary results. Klin Pädiatr 1990, 202: 270    
Voggel S, Abele M, Seitz C, Agaimy A, Vokuhl C, Dirksen U, Bier A, Flaadt T, Classen CF, Claviez A, Schneider DT, Brecht IB Primary lung carcinoma in children and adolescents - Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP). Lung cancer 2021, 160: 66    
Vokuhl C, Oyen F, Häberle B, von Schweinitz D, Schneppenheim R, Leuschner I Small Cell Undifferentiated Hepatoblastomas (SCUD): All Malignant Rhabdoid Tumors? Genes, chromosomes & cancer 2016,    
Vokuhl C, Nourkami-Tutdibi N, Furtwängler R, Gessler M, Graf N, Leuschner I ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study. Pediatric blood & cancer 2018, 65    
Volm M, Mattern J, Stammler G, Royer-Pokora B, Schneider S, Weirich A, Ludwig R Expression of resistance-related proteins in nephroblastoma after chemotherapy. Int J Cancer 1995, 63: 193    
von Schweinitz D, Burger D, Weinel P, Mildenberger H Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH. Klin Pädiatr 1992, 204: 214    
von Schweinitz D, Hadam M, Welte K, Mildenberger H, Pietsch T Production of interleukin-1 beta and interleukin-6 in hepatoblastoma. Int J Cancer 1993, 53: 728    
von Schweinitz D, Burger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol. Klin Pädiatr 1994, 206: 282    
von Schweinitz D, Burger D, Mildenberger H Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89. Eur J Pediatr Surg 1994, 4: 82    
von Schweinitz D, Wischmeyer P, Leuschner I, Schmidt D, Wittekind C, Harms D, Mildenberger H Clinico-pathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer 1994, 30A: 1052    
von Schweinitz D, Gluer S, Mildenberger H Liver tumors in neonates and very young infants. Eur J Pediatr Surg 1995, 5: 72    
von Schweinitz D, Hecker H, Burger D, Mildenberger H Surgical therapy of hepatoblastoma in childhood. Langenbecks Arch Chir 1995, 380: 315    
von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Burger D, Erttmann R, Mildenberger H Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 1995, 30: 845    
von Kries R, Göbel U, Hachmeister A, Kaletsch U, Michaelis J Vitamin K and childhood cancer. BMJ 1996, 313: 199    
von Schweinitz D, Fuchs J, Mildenberger H Surgical strategy in pediatric liver malignancies. Langenbecks Arch Chir Suppl Kongressbd 1996, 113: 1091    
von Schweinitz D, Byrd D, Hecker H, Weinel P, Bode U, Burger D, Erttmann R, Harms D, Mildenberger H Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 1997, 33: 1243    
von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 1997, 74: 593    
von Schweinitz D Identification of risk groups in hepatoblastoma--another step in optimising therapy. Eur J Cancer 2000, 36: 1343    
von Schweinitz D, Faundez A, Teichmann B, Birnbaum T, Koch A, Hecker H, Gluer S, Fuchs J, Pietsch T Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 2000, 85: 151    
von Schweinitz D, Hero B, Berthold F The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 2002, 12: 402    
von Schweinitz D, Kraus J, Albrecht S, Koch A, Fuchs J, Pietsch T Prognostic impact of molecular genetic alterations in hepatoblastoma. Med Pediatr Oncol 2002, 38: 104    
von Schweinitz D Neonatal liver tumours. Semin Neonatol 2003, 8: 403    
Vormoor J, Ritter J, Creutzig U, Schellong G Inzidenz und prognostische Bedeutung von Auerstäbchen bei Kindern mit akuter myeloischer Leukämie in den Studien AML-BFM-78 and -83. Klinische Pädiatrie 1989, 201: 227    
Vormoor J, Ritter J, Creutzig U, Boos J, Heyen P, Ludwig W, Harbott J, Löffler H, Schellong G, Group for Acute myelogenous leukaemia in children under 2 years - experiences of the West German AML Studies BFM-78-83 and -87. British Journal of Cancer 1992, 66 (Suppl.XVIII): 63    
Vormoor J, Boos J, Stahnke K, Jürgens H, Ritter J, Creutzig U Therapy of childhood acute myelogenous leukemias. Annals Hematology 1996, 73: 11    
Vormoor J, Baersch G, Decker S, Hotfilder M, Schafer K, Pelken L, Rube C, van Valen F, Jürgens H, Dockhorn-Dworniczak B Establishment of an In Vivo Model for Pediatric Ewing Tumors by Transplantation into NOD/scid Mice. Pediatr Res 2001, 49: 332    
Vormoor J, Klingebiel T, Jürgens H [Current state of cord blood transplantation in childhood]. Klinische Padiatrie 2002 Jul-Aug; 214: 195    
Vora A, Andreano A, Pui CH, Hunger SP, Schrappe M, Moericke A, Biondi A, Escherich G, Silverman LB, Goulden N, Taskinen M, Pieters R, Horibe K, Devidas M, Locatelli F, Valsecchi MG Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy. Journal of clinical oncology 2016, 34: 919    
Voskaridou E, Ladis V, Kattamis A, Hassapopoulou E, Economou M, Kourakli A, Maragkos K, Kontogianni K, Lafioniatis S, Vrettou E, Koutsouka F, Papadakis A, Mihos A, Eftihiadis E, Farmaki K, Papageorgiou O, Tapaki G, Maili P, Theohari M, Drosou M, Kartasis Z, Aggelaki M, Basileiadi A, Adamopoulos I, Lafiatis I, Galanopoulos A, Xanthopoulidis G, Dimitriadou E, Mprimi A, Stamatopoulou M, Haile ED, Tsironi M, Anastasiadis A, Kalmanti M, Papadopoulou M, Panori E, Dimoxenou P, Tsirka A, Georgakopoulos D, Drandrakis P, Dionisopoulou D, Ntalamaga A, Davros I, Karagiorga M, on behalf of the Greek Haemoglobinopathies Study Group A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births. Annals of hematology 2012, epub ahead of print    
Voth H, Oberthuer A, Simon T, Kahlert Y, Berthold F, Fischer M Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastoma. Molecular cancer research : MCR 2007, 5: 1276    
Voth H, Oberthuer A, Simon T, Kahlert Y, Berthold F, Fischer M Co-regulated expression of HAND2 and DEIN by a bidirectional promoter with asymmetrical activity in neuroblastoma. BMC molecular biology 2009, 10: 28    
Vokuhl C, Nourkami-Tutdibi N, Furtwängler R, Gessler M, Graf N, Leuschner I ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study. Pediatric blood & cancer 2018, 65    
de Vries AC, Bredius RG, Lankester AC, Bierings M, Trebo M, Sedlacek P, Niemeyer CM, Zecca M, Locatelli F, van den Heuvel-Eibrink MM HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia. Haematologica 2009, 94: 302    
van Schaik J, Hoving EW, Müller HL, van Santen HM Hypothalamic-Pituitary Outcome after Treatment for Childhood Craniopharyngioma. Frontiers of hormone research 2021, 54: 47    
Vujanić GM, D'Hooghe E, Graf N, Vokuhl C, Al-Saadi R, Chowdhury T, Pritchard-Jones K, Furtwängler R Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. International journal of cancer 2021, 149: 1332    
Vujanić GM, D'Hooghe E, Graf N, Vokuhl C, Al-Saadi R, Chowdhury T, Pritchard-Jones K, Furtwängler R Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. International journal of cancer 2021, 149: 1332    
Vujanić GM, Graf N, D'Hooghe E, Chowdhury T, Vokuhl C, Al-Saadi R, Pritchard-Jones K, Melchior P, Furtwängler R Outcomes of patients with Wilms' tumour stage III due to positive resection margins only: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies. International journal of cancer 2023, 152: 1640    
63 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.